Seazen Group (01030.HK) Announces Updated Board Composition and Committee Appointments Effective 16 Mar 2026

Bulletin Express
Mar 16

Seazen Group Limited today disclosed an updated roster of directors and committee assignments, effective 16 March 2026.

• Board Composition: The Board now comprises six members—two Executive Directors, one Non-executive Director, and three Independent Non-executive Directors. – Executive Directors: Mr. Lu Zhongming and Mr. Zhou Fudong – Non-executive Director and Chairman: Mr. Wang Xiaosong – Independent Non-executive Directors: Mr. Zhu Zengjin, Mr. Zhong Wei, and Ms. Wu Ke

• Committee Structure: Four specialized committees have been reconfirmed, with chair and member roles allocated as follows. – Audit Committee: Chaired by Ms. Wu Ke; members include Mr. Zhu Zengjin and Mr. Zhong Wei. – Remuneration Committee: Chaired by Mr. Zhu Zengjin; members include Mr. Zhong Wei and Ms. Wu Ke. – Nomination Committee: Chaired by Mr. Zhu Zengjin; members include Mr. Lu Zhongming and Ms. Wu Ke. – Environmental, Social and Governance Committee: Chaired by Mr. Wang Xiaosong; members include Mr. Lu Zhongming and Mr. Zhou Fudong.

The updated governance framework maintains independent oversight with Independent Non-executive Directors holding the chair positions in three of the four committees, while the company’s Chairman, Mr. Wang Xiaosong, leads the ESG Committee.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10